(NYSE: WAT) Waters's forecast annual revenue growth rate of 18.28% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.23%.
Waters's revenue in 2026 is $4,644,249,000.On average, 28 Wall Street analysts forecast WAT's revenue for 2026 to be $640,675,931,831, with the lowest WAT revenue forecast at $620,240,324,743, and the highest WAT revenue forecast at $667,988,906,689. On average, 28 Wall Street analysts forecast WAT's revenue for 2027 to be $707,189,902,978, with the lowest WAT revenue forecast at $669,757,372,687, and the highest WAT revenue forecast at $751,499,801,039.
In 2028, WAT is forecast to generate $749,829,583,152 in revenue, with the lowest revenue forecast at $705,126,692,647 and the highest revenue forecast at $824,498,147,512.